Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease.
Garipidou
V
V
Vakalopoulou
S
S
Zafiriadou
E
E
Kaloutsi
V
V
Tziomalos
K
K
Perifanis
V
V
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation; D008171:Lung Diseases / Q000139:chemically induced* / Q000276:immunology*; D013577:Syndrome; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin